99 related articles for article (PubMed ID: 4376253)
1. [Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by glypentide and other oral antidiabetic agents (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Dec; 30(4):277-81. PubMed ID: 4376253
[No Abstract] [Full Text] [Related]
2. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
[No Abstract] [Full Text] [Related]
3. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
Sánchez-Casals MS; Morell-Mestre J
Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
[No Abstract] [Full Text] [Related]
4. Potential antidiabetic agents. Pyrazolo(3,4-b)pyridines.
Höhn H; Polacek I; Schulze E
J Med Chem; 1973 Dec; 16(12):1340-6. PubMed ID: 4358224
[No Abstract] [Full Text] [Related]
5. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
Davidoff F
R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
[No Abstract] [Full Text] [Related]
6. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
[No Abstract] [Full Text] [Related]
7. When--and how--to use an oral agent.
Shuman CR
Med Times; 1980 May; 108(5):77-81, 85-6. PubMed ID: 7374409
[No Abstract] [Full Text] [Related]
8. Oral hypoglycemic agents and heart.
Manoria P; Manoria P
Indian Heart J; 2007; 59(3):266-72. PubMed ID: 19124937
[No Abstract] [Full Text] [Related]
9. Glypentide: a new hypoglycaemic agent.
Morell J
Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
[No Abstract] [Full Text] [Related]
10. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
Calvet JM; Matarrodona M; Bordas R
Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
[No Abstract] [Full Text] [Related]
11. [The blood-sugar depressing and betacytotrope effect of glibornurid in healthy and in gastric-resected persons (author's transl)].
Grabner W; Matzkies F; Randerbrock V; Berg G
Med Klin; 1973 Aug; 68(34):1101-5. PubMed ID: 4598149
[No Abstract] [Full Text] [Related]
12. [Effect of oral antidiabetic agents on fructose biosynthesis].
Kulagin OL
Eksp Klin Farmakol; 2000; 63(5):44-6. PubMed ID: 11109526
[TBL] [Abstract][Full Text] [Related]
13. [Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease].
Nauck MA; Matthaei S
Dtsch Med Wochenschr; 2005 Apr; 130(17):1091-6. PubMed ID: 15841424
[No Abstract] [Full Text] [Related]
14. Oral hypoglycemic agents.
N Engl J Med; 1977 Aug; 297(7):394-6. PubMed ID: 406566
[No Abstract] [Full Text] [Related]
15. [Pitfalls in treatment with oral antidiabetic agents].
Perusicová J
Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
[TBL] [Abstract][Full Text] [Related]
16. [Clinically important effects of oral antidiabetic drug interactions].
Drzewoski J; Kopff B
Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
[TBL] [Abstract][Full Text] [Related]
17. Rational choice of oral antihyperglycaemic agents.
Chowdhury S; Sengupta N
J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
19. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent)].
Rodríguez-Miñón JL; Herrera Pombo JL; Marrón JA
Rev Clin Esp; 1971 Dec; 123(5):439-42. PubMed ID: 5160567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
